ALDX

Aldeyra Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 5/10
  • Value↓ 4/10
Aldeyra Therapeutics sales and earnings growth
ALDX Growth
Neutral
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 53.61%
  • FCF Y/Y↑ 43.14%
Aldeyra Therapeutics gross and profit margin trends
ALDX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -437.29%
Aldeyra Therapeutics net debt vs free cash flow
ALDX Risk
Great
  • Debt / Equity↓ 0.4
  • Debt / FCF↓ 0.0
  • Interest coverage↓ -13.5

Aldeyra Therapeutics stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks